Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-11-18
1998-06-16
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, 514221, 514258, 514292, 514300, A61K 3144, A61K 31505, A61K 3155
Patent
active
057671176
ABSTRACT:
The present invention provides methods for treating migraine headache. The methods useful according to the invention involve the treatment of patients who experience symptoms of migraine headache with compounds that directly or indirectly activate GABA.sub.A receptors.
REFERENCES:
patent: 5120723 (1992-06-01), Gee et al.
Moskowitz, M. et al., Sumatriptan: A Receptor-Targeted Treatment for Migraine; Annu. Rev. Med. 1993; 44:145-154.
Serensen, K.V.; Valproate: A New Drug in Migraine Prophylaxis; Acta Neurol Scand; 1988; 78:346-348.
Haefely, J. et al., Novel Anxiolytics that Act as Partial Agonists at Benzodiazepine Receptors; TiPS; Nov. 1990; 11:452-456.
Sieghart, W., GABA A Receptors: Ligand-gated CI-ion Channels Modulated by Multiple Drug-Binding Sites; TiPS; Dec. 1992; 13:446-450.
Guisti, L. et al., Sex Steroid Hormones and GABA A Receptor Complex Modulation; GABAergic Syaptic Transmission; 1992; 133-141.
Jussofie, A.; Brain Area Specific Differences in the Effects of Neuroactive Steroids on the GABA A Receptor Complexes Following Acute Treatment with Anaesthetically Active Steroids; Acta Endo. 1993; 129: 480-485.
Beckham, J. et al., The Relationship of Ovarian Steroids, Headache Activity and Menstrual Distress: A Pilot Study with Female Migraineurs; Headache 1992; 32:292-297.
Moskowitz, M.; Neurovascular and Molecular Mechanisms in Migraine Headaches; Cerebrovascular and Brain Metabolism Reviews; 5:159-177; 1993.
Moskowitz, M. Neurogenic Versus Vascular Mechanisms of Sumatriptan and Ergot Alkaloids in Migraine; Trends in Pharm. Sciences; Aug. 1992; 13:307-311.
Hering, R. et al., Sodium Valproate in the Treatment of Cluster Headace: An Open Clinical Trial; Cephalalgia 1989; 9:195-198.
Sodium Valproate in the Prophylactic Treatment of Migraine: A Double-Blind Study versus Placebo; Cephalalgia 1992; 12:81-84.
Mathew, N.; Valproate in the Treatment of Persistent Chronic Daily Headache. An Open Study; Headache 1991; 31:71-74.
Jones, M. et al.; Effect of Treatment with Sodium Valproate and Diazepam on Plasma Corticotropin in Nelson's Syndrome; the Lancet, May 30, 1991; 1179-1181.
Frye, C. et al., Progesterone Metabolites, Effective in the GABA A Receptor Complex, Attenuate Pain Sensitivity in Rats; Brain Research 643 (1994) 194-203.
Serensen, K.V.; Valproate: A New Drug in Migraine Prophylaxis; Acta Neurol. Scand., 1988:78:346-348.
Hoke, J. et al.; Pharmacokinetics of Vigabatrin Following Single and Multiple Oral Doses in Normal Volunteers; J. Clin. Pharmac. 1993:33:458-462.
Browne, T.R. et al.; Vigabatrin for Refractory Complex Partial Seizures: Multicenter Single-Blind Study with Long-term Follow-up; Neurology 1987:37:184-189.
Ring, H.A. et al.; Vigabatrin: Rational treatment for Chronic Epilepsy; J. Neurology, Neurosurgery and Psych.; 1990;53:1051-55.
Kalviainen, R. et al.; Place of Newer Antiepileptic Drugs in the Treatment of Epilepsy; Drugs 46(6):1009-1024, 1993.
Snyder, S.; Drug and Neurotransmitter Receptors; New Perspective with Clinical Relevance; JAMA, Jun. 2, 1989 261:3126-3129.
Schove, L.T., Bioorganic & Medicinal Chemistry, 2(10):1029-1049 (1994).
TenBrink, R.E., J. Med. Chem., 37:758-768 (1994).
Lee, C.M., et al., Neuroscience Letters, 127:237-241 (1991).
Bennett, D.A., et al., Drug Development Research, 4:75-82 (1984).
Martin, J.R., et al., Drug Development Research, 36:141-149 (1995).
Fryer, R.I., et al., Journal of Medicinal Chem., 36:1669-1673 (1993).
Hollinshead, S.P., et al., J. Med. Chem., 33:1062-1069 (1990).
Marder, M., et al., Biochemical and Biophysical Research Communication, 223:384-389 (1996).
Guerrini, G., et al., Eur. J. Med. Chem. (1996) 31, 259-272.
Spivack Phyllis G.
The General Hospital Corporation
LandOfFree
Method for treating vascular headaches does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating vascular headaches, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating vascular headaches will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726241